Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 35   

Articles published

ARNA 2.15 +0.02 (0.94%)
price chart
South Korea's Ildong Pharma To License Arena Pharma Drug
29, 2012) - U.S.-based Arena Pharmaceuticals, Inc. has licensed its internally discovered thrombosis drug, temanogrel, to Seoul, Korea-based Ildong Pharmaceutical Co.
Vivus Or Arena: Who Has The Edge?
Two of the three major players in the treatment of obesity, VIVUS Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals Inc. (NASDAQ:ARNA) released their financial results and provided an update on recent developments.
Cultural synergy at Millennium Pharmaceuticals
It's the way of the business world. When a global drug company takes over a biotechnology firm, it can be expected to streamline operations, decree new management structures, and impose its rigid Big Pharma corporate culture on the locals. But ...
Prescription drug deaths: Two stories
Pete Jackson attended his brother-in-law's funeral along with his daughter, Emily, six years ago. He never dreamed it would be the last day of his daughter's life.
Maximizing Value and Minimizing Risk with Remote Workers
For me, being able to work remotely is one of the greatest gifts of the information age. It allowed me to help raise my daughters in the '80s and '90s, live almost four hours from a major airport, and now I'm able to visit my granddaughters in Chicago ...
Vivus Inc: This Hedge Fund Just Went Activist
And then there's Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and a few other competitors. Belviq is the major competition to Qsymia, and with far fewer contraindications, Belviq is more likely to be the first-prescribed drug between Qsymia and Bevliq ...
Jawbone's Up and Fitbit's One: Which tiny fitness gadget is best? (review)
With the Fitbit One, the company took all of its experience in this arena and crafted it into its most compelling device yet.
Indian board rejects AstraZeneca's patent plea on cancer drug
Natco and another domestic drugmaker, G. M. Pharma, had opposed the initial patent application for AstraZeneca quinazoline derivative.
Amgen Therapy Slims Monkeys as Study Seeks Obesity Drug
An antibody discovered by Amgen Inc. researchers reduces weight and increases glucose tolerance in monkeys, according to a study, potentially opening up a new approach for treating obesity and diabetes in humans.
Girls need just-in-case birth control prescriptions, pediatrics group says
"Improvements in medicine are shifting the arena for discussing reproductive ethics from abortion clinics and surgical procedures to choices made by individual women talking to their doctor, nurse, pharmacist and others whom they trust.